Healthline
Medscape
November 15, 2024
Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended refusal of marketing authorizations for: Cinainu (allium/citrus/Paullinia/cacao), an herbal medicine intended to treat moderate to […]
November 15, 2024
Following a consultation with its emergency task force, the European Medicines Agency (EMA) has backed a drug for adult patients with acute respiratory distress syndrome (ARDS) […]
November 15, 2024
The European Medicines Agency (EMA) recommended eight medicines for approval this month, including two cancer drugs for treating non-small cell lung cancer (NSCLC). Augtyro for Advanced […]
November 15, 2024
The European Medicines Agency’s (EMA’s) Committee for Medicinal Products for Human Use (CHMP) has recommended granting marketing authorization for Leqembi (lecanemab) to treat mild cognitive impairment […]